PAH patients with cardiovascular disease risk had similar hospitalization and mortality rates as those without after a ...

Columnist Colleen Steele says that glimmers are like an antidote to some of the events that spark her caregiving anxiety.

Columnist Anna Jeter is delighted to find themes that are relevant to her life in the fictional narratives of writers and ...

Following the first sale of Yutrepia to treat certain types of PH, Liquidia has received $50 million under its financing ...

A Phase 3 clinical trial testing the experimental daily oral treatment ralinepag in people with PAH has completed enrollment.

Adding Winrevair treatment significantly reduced the risk of clinical worsening in people with a recent PAH diagnosis, per a ...

With patient enrollment now complete, topline results are expected early next year from a Phase 3 trial testing PAH treatment ...

Opsumit (macitentan), an oral once-daily therapy, is approved to treat the symptoms and help slow the progression of PAH. It is also being investigated as a possible treatment for other types PH, ...